{"id":16707,"external_id":"11184157","country_code":"PT","object":"PERTUzumab 60 mg/ml + TRASTUzumab 60 mg/ml","procedure_type":"Ajuste Direto Regime Geral","contract_type":"Aquisição de bens móveis","cpv_code":"33000000","base_price":85107.0,"total_effective_price":85107.0,"publication_date":"2025-01-23","celebration_date":"2024-12-09","location":"Portugal, Porto, Porto","bidder_count":null,"contracting_entity":{"name":"Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.","tax_identifier":"506362299","country_code":"PT","is_public_body":true},"bidders":[],"winners":[{"name":"ROCHE FARMACEUTICA QUIMICA LDA","tax_identifier":"500233810","is_company":true}],"flags":[{"flag_type":"C3_MISSING_MANDATORY_FIELDS","severity":"low","score":20,"details":{"rule":"C3 missing mandatory fields: cpv_code","missing_fields":["cpv_code"]},"evaluation":{"version":"2026-10-30.1","missing_fields":[],"status":"evaluated","experimental":false,"recorded_version":null},"fired_at":"2026-03-06T17:28:57Z"}],"risk_score":20,"data_source":{"name":"QuemFatura.pt","source_type":"api","last_synced_at":"2026-02-27T18:09:03Z"},"evidence_metadata":{"source_url":null,"resource_version":null,"ingested_at":null,"value_basis":"legacy_reported_value","contracted_price":null,"indicator_versions":[],"completeness":{"present_fields":4,"expected_fields":5,"missing_fields":["contracted_price"]},"evaluation_status":"indicator_recorded"},"exported_at":"2026-11-09T15:10:17Z"}